Development of a novel calculator to predict gonadotropin dose and oocyte yield in oocyte cryopreservation cycles
- PMID: 39775731
- PMCID: PMC11871197
- DOI: 10.1007/s10815-024-03372-7
Development of a novel calculator to predict gonadotropin dose and oocyte yield in oocyte cryopreservation cycles
Abstract
Purpose: To develop a predictive model for estimating the total dose of gonadotropins and the number mature oocytes in planned oocyte cryopreservation cycles.
Methods: In this retrospective study, oocyte cryopreservation cycles recorded in the Society for Assisted Reproductive Technology Clinic Outcome Reporting System Database from 2013 to 2018 were analyzed. Bivariate copula additive models for location, scale, and shape were performed to create a predictive model for estimating total dose of gonadotropins and number of mature oocytes.
Results: A total of 15,806 oocyte cryopreservation cycles between 2013 and 2018 were included in the analysis. The average age of participants was 35.4 years, the mean duration of stimulation was 11.8 days, and the average number of mature oocytes retrieved was 11.8. The treatment dose increased with age, FSH levels, BMI ≥ 35 kg/m2, smoking, and history of diminished ovarian reserve, while it decreased with increasing AMH, ovulatory disorder, and BMI < 25 kg/m2. The number of mature oocytes retrieved was positively correlated with AMH and negatively correlated with age, FSH levels, Asian race, and diminished ovarian reserve. With a maximum gonadotropin dosage of 450 IU per day for 12 ± 3 days of stimulation and a tolerance level of six mature oocytes, the predictive model achieved 70% accuracy. An interactive version of the equation was created as an online tool.
Conclusions: We developed a predictive model to estimate the total treatment dosage and the number of mature oocytes. This calculator, utilizing objective patient variables, can assist in patient counseling prior to planned oocyte cryopreservation cycles.
Keywords: Egg freezing; Fertility preservation; Oocyte cryopreservation; Patient counseling.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Randomized controlled trial to evaluate the impact of follicle priming on IVM outcomes in women with polycystic ovaries: CFA versus FSH-B.Hum Reprod. 2025 Jun 1;40(6):1127-1137. doi: 10.1093/humrep/deaf053. Hum Reprod. 2025. PMID: 40194780 Clinical Trial.
-
Safety and effectiveness of controlled ovarian stimulation and oocyte retrieval during prepubertal and peripubertal period.J Assist Reprod Genet. 2024 Oct;41(10):2823-2830. doi: 10.1007/s10815-024-03262-y. Epub 2024 Sep 19. J Assist Reprod Genet. 2024. PMID: 39297990
-
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2024 Jan 4;1:CD012693. doi: 10.1002/14651858.CD012693.pub3. PMID: 29388198 Free PMC article. Updated.
-
Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.Curr Pharm Biotechnol. 2017 Nov 10;18(8):609-613. doi: 10.2174/1389201018666170808122531. Curr Pharm Biotechnol. 2017. PMID: 28786354
-
Hematologic cancers in women: from fertility preservation to post-cancer fertility outcomes.Hum Reprod. 2025 Jul 1;40(7):1315-1324. doi: 10.1093/humrep/deaf071. Hum Reprod. 2025. PMID: 40302200
References
-
- Matthews TJ, Hamilton BE. First births to older women continue to rise. NCHS Data Brief. 2014;152:1–8. - PubMed
-
- Martin JA, et al. Births: final data for 2019. Natl Vital Stat Rep. 2021;70(2):1–51. - PubMed
-
- Mikwar M, MacFarlane AJ, Marchetti F. Mechanisms of oocyte aneuploidy associated with advanced maternal age. Mutat Res/Rev Mutat Res. 2020;785:108320. - PubMed
-
- Johnston M, et al. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection. Hum Reprod. 2021;36(3):624–35. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources